Literature DB >> 23404368

Operational dissection of β-amyloid cytopathic effects on cultured neurons.

Noelle Callizot1, Maud Combes, Rémy Steinschneider, Philippe Poindron.   

Abstract

Alzheimer disease (AD) affects mainly people over the age of 65 years, suffering from different clinical symptoms such as progressive decline in memory, thinking, language, and learning capacity. The toxic role of β-amyloid peptide (Aβ) has now shifted from insoluble Aβ fibrils to smaller, soluble oligomeric Aβ aggregates. The urgent need for efficient new therapies is high; robust models dissecting the physiopathological aspects of the disease are needed. We present here a model allowing study of four cytopathic effects of Aβ oligomers (AβO): oxidative stress, loss of synapses, disorganization of the neurite network, and cellular death. By generating a solution of AβO and playing on the concentration of and time of exposure to AβO, we have shown that it was possible to reproduce early effects (oxidative stress) and the long-term development of structural alterations (death of neurons). We have shown that 1) all toxic events were linked to AβO according to a specific timing and pathway and 2) AβO were probably the key intermediates in AD pathogenesis. The present model, using Aβ peptide solution containing AβO, reproduced essential neuropathological features of AD; the effects involved were similar whatever the kind of neurons tested (cortical vs. hippocampal). By using a single system, it was possible to embrace all toxic mechanisms at defined times and concentrations, to study each involved pathway, and to study the effects of new molecules on the different neurotoxic pathways responsible for development of AD.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404368     DOI: 10.1002/jnr.23193

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Effects of Amylin Against Amyloid-β-Induced Tauopathy and Synapse Loss in Primary Neurons.

Authors:  Qini Gan; Hongbo Yao; Hana Na; Heather Ballance; Qiushan Tao; Lorene Leung; Hua Tian; Haihao Zhu; Benjamin Wolozin; Wei Qiao Qiu
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Donecopride, a Swiss army knife with potential against Alzheimer's disease.

Authors:  Christophe Rochais; Cédric Lecoutey; Katia Hamidouche; Patrizia Giannoni; Florence Gaven; Eleazere Cem; Serge Mignani; Kevin Baranger; Thomas Freret; Joël Bockaert; Santiago Rivera; Michel Boulouard; Patrick Dallemagne; Sylvie Claeysen
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

3.  N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

Authors:  Shih Chang Hsueh; Weiming Luo; David Tweedie; Dong Seok Kim; Yu Kyung Kim; Inho Hwang; Jung-Eun Gil; Baek-Soo Han; Yung-Hsiao Chiang; Warren Selman; Barry J Hoffer; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-30

4.  The metabolite GLP-1 (9-36) is neuroprotective and anti-inflammatory in cellular models of neurodegeneration.

Authors:  Yazhou Li; Elliot J Glotfelty; Tobias Karlsson; Lowella V Fortuno; Brandon K Harvey; Nigel H Greig
Journal:  J Neurochem       Date:  2021-10-21       Impact factor: 5.546

5.  Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy.

Authors:  Ilya Chumakov; Serguei Nabirotchkin; Nathalie Cholet; Aude Milet; Aurélie Boucard; Damien Toulorge; Yannick Pereira; Esther Graudens; Sory Traoré; Julie Foucquier; Mickael Guedj; Emmanuel Vial; Noëlle Callizot; Rémy Steinschneider; Tangui Maurice; Viviane Bertrand; Catherine Scart-Grès; Rodolphe Hajj; Daniel Cohen
Journal:  Sci Rep       Date:  2015-01-08       Impact factor: 4.379

6.  Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration.

Authors:  Patricia Richard; Lucie Kozlowski; Hélène Guillorit; Patrice Garnier; Nicole C McKnight; Antoine Danchin; Xavier Manière
Journal:  PLoS One       Date:  2021-08-11       Impact factor: 3.240

7.  Neuroprotective Effect of CR-777, a Glutathione Derivative of Withaferin A, Obtained through the Bioconversion of Withania somnifera (L.) Dunal Extract by the Fungus Beauveria bassiana.

Authors:  Chérif Rabhi; Guillaume Arcile; Géraldine Le Goff; Christian Da Costa Noble; Jamal Ouazzani
Journal:  Molecules       Date:  2019-12-16       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.